Aarti Pharmalabs Limited (BOM:543748)

Market Cap	74.05B -2.8%
Revenue (ttm)	19.69B +1.2%
Net Income	2.05B -23.1%
EPS	22.56 -23.2%
Shares Out	n/a
PE Ratio	36.15
Forward PE	49.80
Dividend	3.50 (0.43%)
Ex-Dividend Date	Sep 15, 2026

Volume	25,300
Open	825.75
Previous Close	829.30
Day's Range	807.75 - 837.70
52-Week Range	583.85 - 946.45
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About Aarti Pharmalabs

Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides con...

• Industry: Pharmaceutical Preparations
• Founded: 2019
• Employees: 2,162
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543748

Financial Performance

In fiscal year 2026, Aarti Pharmalabs's revenue was 18.19 billion, a decrease of -13.98% compared to the previous year's 21.15 billion. Earnings were 1.75 billion, a decrease of -35.86%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 22, 2026

Data Sources Report a data error